MINUTES
About Minutes
Back to latest

HealthZealand, Roche obesity drug helps patients lose up to 9.2% in mid-stage trial

Zealand Pharma said Wednesday that its experimental drug, being developed with Roche, helped people who are overweight or obese and have type 2 diabetes lose as much as 9.2% of their body weight in a mid-stage trial.

obesity drugclinical trialZealand PharmaRoche

RReuters★★☆☆☆2026-10-07 19:50Original

Zealand, Roche obesity drug helps patients lose up to 9.2% in mid-stage trial
Zealand, Roche obesity drug helps patients lose up to 9.2% in mid-stage trialHealth